Dr. Ghandehari is a Professor and George S. and Dolores Doré Eccles Presidential Endowed Chair in the Departments of Pharmaceutics and Pharmaceutical Chemistry, Professor, Biomedical Engineering, and Director of Utah Center for Nanomedicine. His research focuses on the design of recombinant polymers for localized drug delivery, targeted delivery of polymer therapeutics to solid tumors, oral delivery of chemotherapeutics, and assessing the biocompatibility of silica and dendritic nano constructs. Dr. Ghandehari is Editor in Chief of Advanced Drug Delivery Reviews, Fellow of the American Institute for Medical and Biological Engineering, the American Association of Pharmaceutical Scientists, and Controlled Release Society, and serves on boards of several drug delivery journals and organizations. He received his BS in Pharmacy and Ph.D. in Pharmaceutics and Pharmaceutical Chemistry from the University of Utah.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc